These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 23826353)

  • 41. No Outbreak of Vancomycin and Linezolid Resistance in Staphylococcal Pneumonia over a 10-Year Period.
    Yayan J; Ghebremedhin B; Rasche K
    PLoS One; 2015; 10(9):e0138895. PubMed ID: 26398276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased activity of linezolid in combination with rifampicin in a murine pneumonia model due to MRSA.
    Zhou YF; Xiong YQ; Tao MT; Li L; Bu MX; Sun J; Liao XP; Liu YH
    J Antimicrob Chemother; 2018 Jul; 73(7):1899-1907. PubMed ID: 29897466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Time-Course Transcriptome Analysis of the Lungs of Mice Challenged with Aerosols of Methicillin-Resistant
    Zhao Y; Zhai L; Qin T; Hu L; Wang J; Zhang Z; Sui C; Zhang L; Zhou D; Lv M; Yang W
    Biomolecules; 2023 Feb; 13(2):. PubMed ID: 36830716
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rapid Detection of Methicillin-Resistant Staphylococcus aureus in BAL: A Pilot Randomized Controlled Trial.
    Paonessa JR; Shah RD; Pickens CI; Lizza BD; Donnelly HK; Malczynski M; Qi C; Wunderink RG
    Chest; 2019 May; 155(5):999-1007. PubMed ID: 30776365
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
    Niederman MS; Chastre J; Solem CT; Wan Y; Gao X; Myers DE; Haider S; Li JZ; Stephens JM
    Clin Ther; 2014 Sep; 36(9):1233-1243.e1. PubMed ID: 25066668
    [TBL] [Abstract][Full Text] [Related]  

  • 46. In vitro activity of TR-700, the antibacterial moiety of the prodrug TR-701, against linezolid-resistant strains.
    Shaw KJ; Poppe S; Schaadt R; Brown-Driver V; Finn J; Pillar CM; Shinabarger D; Zurenko G
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4442-7. PubMed ID: 18838596
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of synergy between beta-lactams and anti-methicillin-resistant Staphylococcus aureus agents from the standpoint of strain characteristics and binding action.
    Ono D; Yamaguchi T; Hamada M; Sonoda S; Sato A; Aoki K; Kajiwara C; Kimura S; Fujisaki M; Tojo H; Sasaki M; Murakami H; Kato K; Ishii Y; Tateda K
    J Infect Chemother; 2019 Apr; 25(4):273-280. PubMed ID: 30713034
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Predictors of clinical success among a national Veterans Affairs cohort with methicillin-resistant Staphylococcus aureus pneumonia.
    Caffrey AR; Morrill HJ; Puzniak LA; LaPlante KL
    Clin Ther; 2014 Apr; 36(4):552-9. PubMed ID: 24631473
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vancomycin versus linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia: implications of the ZEPHyR trial.
    Alaniz C; Pogue JM
    Ann Pharmacother; 2012 Oct; 46(10):1432-5. PubMed ID: 22947593
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of teicoplanin and linezolid therapies in patients with methicillin-resistant Staphylococcus aureus pneumonia acquired from respiratory intensive care unit].
    Taşbakan MS; Korkmaz Ekren P; Pullukçu H; Başarık B; Susur A; Aydemir S; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2010 Jul; 44(3):357-66. PubMed ID: 21063985
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic evaluation of linezolid administered intravenously in obese patients with pneumonia.
    Xie F; Mantzarlis K; Malliotakis P; Koulouras V; Degroote S; Koulenti D; Blot S; Boussery K; Van Bocxlaer J; Colin P;
    J Antimicrob Chemother; 2019 Mar; 74(3):667-674. PubMed ID: 30535122
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Acute alcohol intoxication impairs methicillin-resistant Staphylococcus aureus clearance in the lung by impeding epithelial production of Reg3γ.
    Choi SM; McAleer JP; Trevejo-Nunez G; Pociask DA; Armentrout RA; Chen K; Kolls JK
    Infect Immun; 2014 Apr; 82(4):1402-7. PubMed ID: 24421048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Meta-analysis of vancomycin versus linezolid in pneumonia with proven methicillin-resistant Staphylococcus aureus.
    Kato H; Hagihara M; Asai N; Shibata Y; Koizumi Y; Yamagishi Y; Mikamo H
    J Glob Antimicrob Resist; 2021 Mar; 24():98-105. PubMed ID: 33401013
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transcription of inflammatory genes in the lung after infection with community-associated methicillin-resistant Staphylococcus aureus: a role for panton-valentine leukocidin?
    Montgomery CP; Daum RS
    Infect Immun; 2009 May; 77(5):2159-67. PubMed ID: 19237525
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of weight on treatment efficacy and safety in complicated skin and skin structure infections and nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
    Puzniak LA; Morrow LE; Huang DB; Barreto JN
    Clin Ther; 2013 Oct; 35(10):1557-70. PubMed ID: 24011955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cost-effectiveness of linezolid vs vancomycin in suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia in Germany.
    De Cock E; Krueger WA; Sorensen S; Baker T; Hardewig J; Duttagupta S; Müller E; Piecyk A; Reisinger E; Resch A
    Infection; 2009 Apr; 37(2):123-32. PubMed ID: 19277465
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release of extracellular superoxide dismutase into alveolar fluid protects against acute lung injury and inflammation in
    Sul C; Lewis C; Dee N; Burns N; Oshima K; Schmidt E; Vohwinkel C; Nozik E
    Am J Physiol Lung Cell Mol Physiol; 2023 Apr; 324(4):L445-L455. PubMed ID: 36749572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.
    Mendes RE; Deshpande LM; Smyth DS; Shopsin B; Farrell DJ; Jones RN
    J Clin Microbiol; 2012 Nov; 50(11):3694-702. PubMed ID: 22972817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activity of linezolid and tedizolid against clinical isolates of methicillin-resistant and methicillin and linezolid resistant Staphylococcus aureus: an in vitro comparison.
    Peñuelas M; Candel FJ; Lejarraga C; López-González L; Viñuela-Prieto JM; López de Mendoza D
    Rev Esp Quimioter; 2016 Oct; 29(5):255-8. PubMed ID: 27374726
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative efficacy of human-simulated epithelial lining fluid exposures of tedizolid, linezolid and vancomycin in neutropenic and immunocompetent murine models of staphylococcal pneumonia.
    Kidd JM; Abdelraouf K; Nicolau DP
    J Antimicrob Chemother; 2019 Apr; 74(4):970-977. PubMed ID: 30561650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.